Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Gall Insider Profile
4 Followers
Matthew Gall, CFO at iTeos Therapeutics, holds 65.43K shares in iTeos Therapeutics (Ticker: ITOS). Most recently, Matthew Gall Bought $5,000 shares of iTeos Therapeutics on Nov 19, 2024 for an estimated value of 38.60K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+38.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Matthew Gall holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Gall
Matthew Gall's Trading History
List of latest transactions for each holding click on a transaction to see Matthew Gall's performance on stock
You May Also Like
Matthew Gall insider profile FAQ
What is the percentage of profitable transactions made by Matthew Gall?
The percentage of profitable transactions made by Matthew Gall is 75%.
What is the average return per transaction made by Matthew Gall?
The average return per transaction made by Matthew Gall is 38.50%.
What stocks does Matthew Gall hold?
Matthew Gall holds: ITOS stocks.
What was Matthew Gall’s latest transaction?
Matthew Gall latest transaction was an Informative Buy of $38.60K.
What was Matthew Gall's most profitable transaction?
Matthew Gall’s most profitable transaction was an Informative Buy of ITOS stock on June 16, 2021. The return on the trade was 83.80%.
What is Matthew Gall's role in iTeos Therapeutics?
Matthew Gall's role in iTeos Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.